Total submissions: 6
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Eurofins Ntd Llc |
RCV000824719 | SCV000331478 | uncertain significance | not provided | 2015-10-08 | criteria provided, single submitter | clinical testing | |
Gene |
RCV000824719 | SCV000568148 | benign | not provided | 2020-07-15 | criteria provided, single submitter | clinical testing | This variant is associated with the following publications: (PMID: 24046065) |
Ambry Genetics | RCV002313246 | SCV000848034 | benign | Inborn genetic diseases | 2016-07-18 | criteria provided, single submitter | clinical testing | This alteration is classified as benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Revvity Omics, |
RCV000824719 | SCV003830304 | uncertain significance | not provided | 2021-02-08 | criteria provided, single submitter | clinical testing | |
Ce |
RCV000824719 | SCV004137976 | likely benign | not provided | 2024-05-01 | criteria provided, single submitter | clinical testing | CACNA1A: BS1 |
Gene |
RCV000485876 | SCV000714106 | likely benign | not specified | 2017-03-31 | flagged submission | clinical testing | This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. |